Atlas Trials

Borderline Pancreas Study: FOLFIRINOX +SBRT

Clinical trial NCT01992705 · COMPLETED

Trial details

NCT number
NCT01992705
Sponsor
University of Maryland, Baltimore
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Resectable Pancreatic Cancer
Start date
2014-03-01
Primary completion
2018-09-27
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.